BDBM231661 DEt (12)::US10668094, Compound DEt

SMILES: CCN1CCC(O[C@H]2[C@@H](O)C[C@H](O[C@H]3[C@@H](O)C[C@H](O[C@H]4CC[C@@]5(C)C(CCC6C5C[C@H](O)[C@]5(C)[C@H](CC[C@]65O)C5=CC(=O)OC5)C4)O[C@H]3C)O[C@H]2C)OC(C)C1

InChI Key: InChIKey=LCGZRYIGXYRVKQ-ZVOBLZRGSA-N

Data: 6 KI

Find this compound or compounds like it in BindingDB or PDB:

Substructure Similarity at least:  must be >=0.5 Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 6 hits for monomerid = 231661   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kcal/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
Na,K-ATPase alpha2beta3 (Homo sapiens (Human))	BDBM231661 (DEt (12) | US10668094, Compound DEt) Show SMILES CCN1CCC(O[C@H]2[C@@H](O)C[C@H](O[C@H]3[C@@H](O)C[C@H](O[C@H]4CC[C@@]5(C)C(CCC6C5C[C@H](O)[C@]5(C)[C@H](CC[C@]65O)C5=CC(=O)OC5)C4)O[C@H]3C)O[C@H]2C)OC(C)C1 |r,t:42| Show InChI InChI=1S/C43H69NO12/c1-7-44-15-12-36(51-23(2)21-44)55-39-24(3)53-38(20-33(39)46)56-40-25(4)52-37(19-32(40)45)54-28-10-13-41(5)27(17-28)8-9-30-31(41)18-34(47)42(6)29(11-14-43(30,42)49)26-16-35(48)50-22-26/h16,23-25,27-34,36-40,45-47,49H,7-15,17-22H2,1-6H3/t23?,24-,25-,27?,28-,29+,30?,31?,32-,33-,34-,36?,37-,38-,39+,40+,41-,42-,43-/m0/s1	PDB UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	14.4	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Yeda Research and Development Co. Ltd. US Patent					Assay Description To screen for isoform selectivity of the digoxin derivatives we compared inhibition of Na,K-ATPase activity of purified detergent-soluble human isofo...				US Patent US10668094 (2020)
					More data for this Ligand-Target Pair
Na,K-ATPase alpha2beta2 (Homo sapiens (Human))	BDBM231661 (DEt (12) | US10668094, Compound DEt) Show SMILES CCN1CCC(O[C@H]2[C@@H](O)C[C@H](O[C@H]3[C@@H](O)C[C@H](O[C@H]4CC[C@@]5(C)C(CCC6C5C[C@H](O)[C@]5(C)[C@H](CC[C@]65O)C5=CC(=O)OC5)C4)O[C@H]3C)O[C@H]2C)OC(C)C1 |r,t:42| Show InChI InChI=1S/C43H69NO12/c1-7-44-15-12-36(51-23(2)21-44)55-39-24(3)53-38(20-33(39)46)56-40-25(4)52-37(19-32(40)45)54-28-10-13-41(5)27(17-28)8-9-30-31(41)18-34(47)42(6)29(11-14-43(30,42)49)26-16-35(48)50-22-26/h16,23-25,27-34,36-40,45-47,49H,7-15,17-22H2,1-6H3/t23?,24-,25-,27?,28-,29+,30?,31?,32-,33-,34-,36?,37-,38-,39+,40+,41-,42-,43-/m0/s1	PDB UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	16.4	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Yeda Research and Development Co. Ltd. US Patent					Assay Description To screen for isoform selectivity of the digoxin derivatives we compared inhibition of Na,K-ATPase activity of purified detergent-soluble human isofo...				US Patent US10668094 (2020)
					More data for this Ligand-Target Pair
Na,K-ATPase alpha2beta1 (Homo sapiens (Human))	BDBM231661 (DEt (12) | US10668094, Compound DEt) Show SMILES CCN1CCC(O[C@H]2[C@@H](O)C[C@H](O[C@H]3[C@@H](O)C[C@H](O[C@H]4CC[C@@]5(C)C(CCC6C5C[C@H](O)[C@]5(C)[C@H](CC[C@]65O)C5=CC(=O)OC5)C4)O[C@H]3C)O[C@H]2C)OC(C)C1 |r,t:42| Show InChI InChI=1S/C43H69NO12/c1-7-44-15-12-36(51-23(2)21-44)55-39-24(3)53-38(20-33(39)46)56-40-25(4)52-37(19-32(40)45)54-28-10-13-41(5)27(17-28)8-9-30-31(41)18-34(47)42(6)29(11-14-43(30,42)49)26-16-35(48)50-22-26/h16,23-25,27-34,36-40,45-47,49H,7-15,17-22H2,1-6H3/t23?,24-,25-,27?,28-,29+,30?,31?,32-,33-,34-,36?,37-,38-,39+,40+,41-,42-,43-/m0/s1	PDB UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	18.5	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Weizmann Institute of Science					Assay Description Inhibition of Na,K-ATPase activity of the detergent-soluble α1β1, α2β1, and α3β1 complexes by CGs was done exactly as d...				J Biol Chem 289: 21153-62 (2014) Article DOI: 10.1074/jbc.M114.557629 BindingDB Entry DOI: 10.7270/Q2G44P6T
					More data for this Ligand-Target Pair
Na,K-ATPase alpha2beta1 (Homo sapiens (Human))	BDBM231661 (DEt (12) | US10668094, Compound DEt) Show SMILES CCN1CCC(O[C@H]2[C@@H](O)C[C@H](O[C@H]3[C@@H](O)C[C@H](O[C@H]4CC[C@@]5(C)C(CCC6C5C[C@H](O)[C@]5(C)[C@H](CC[C@]65O)C5=CC(=O)OC5)C4)O[C@H]3C)O[C@H]2C)OC(C)C1 |r,t:42| Show InChI InChI=1S/C43H69NO12/c1-7-44-15-12-36(51-23(2)21-44)55-39-24(3)53-38(20-33(39)46)56-40-25(4)52-37(19-32(40)45)54-28-10-13-41(5)27(17-28)8-9-30-31(41)18-34(47)42(6)29(11-14-43(30,42)49)26-16-35(48)50-22-26/h16,23-25,27-34,36-40,45-47,49H,7-15,17-22H2,1-6H3/t23?,24-,25-,27?,28-,29+,30?,31?,32-,33-,34-,36?,37-,38-,39+,40+,41-,42-,43-/m0/s1	PDB UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	23.2	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Yeda Research and Development Co. Ltd. US Patent					Assay Description To screen for isoform selectivity of the digoxin derivatives we compared inhibition of Na,K-ATPase activity of purified detergent-soluble human isofo...				US Patent US10668094 (2020)
					More data for this Ligand-Target Pair
Na,K-ATPase alpha1beta1 (Homo sapiens (Human))	BDBM231661 (DEt (12) | US10668094, Compound DEt) Show SMILES CCN1CCC(O[C@H]2[C@@H](O)C[C@H](O[C@H]3[C@@H](O)C[C@H](O[C@H]4CC[C@@]5(C)C(CCC6C5C[C@H](O)[C@]5(C)[C@H](CC[C@]65O)C5=CC(=O)OC5)C4)O[C@H]3C)O[C@H]2C)OC(C)C1 |r,t:42| Show InChI InChI=1S/C43H69NO12/c1-7-44-15-12-36(51-23(2)21-44)55-39-24(3)53-38(20-33(39)46)56-40-25(4)52-37(19-32(40)45)54-28-10-13-41(5)27(17-28)8-9-30-31(41)18-34(47)42(6)29(11-14-43(30,42)49)26-16-35(48)50-22-26/h16,23-25,27-34,36-40,45-47,49H,7-15,17-22H2,1-6H3/t23?,24-,25-,27?,28-,29+,30?,31?,32-,33-,34-,36?,37-,38-,39+,40+,41-,42-,43-/m0/s1	PDB UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	53	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Weizmann Institute of Science					Assay Description Inhibition of Na,K-ATPase activity of the detergent-soluble α1β1, α2β1, and α3β1 complexes by CGs was done exactly as d...				J Biol Chem 289: 21153-62 (2014) Article DOI: 10.1074/jbc.M114.557629 BindingDB Entry DOI: 10.7270/Q2G44P6T
					More data for this Ligand-Target Pair
Na,K-ATPase alpha1beta1 (Homo sapiens (Human))	BDBM231661 (DEt (12) | US10668094, Compound DEt) Show SMILES CCN1CCC(O[C@H]2[C@@H](O)C[C@H](O[C@H]3[C@@H](O)C[C@H](O[C@H]4CC[C@@]5(C)C(CCC6C5C[C@H](O)[C@]5(C)[C@H](CC[C@]65O)C5=CC(=O)OC5)C4)O[C@H]3C)O[C@H]2C)OC(C)C1 |r,t:42| Show InChI InChI=1S/C43H69NO12/c1-7-44-15-12-36(51-23(2)21-44)55-39-24(3)53-38(20-33(39)46)56-40-25(4)52-37(19-32(40)45)54-28-10-13-41(5)27(17-28)8-9-30-31(41)18-34(47)42(6)29(11-14-43(30,42)49)26-16-35(48)50-22-26/h16,23-25,27-34,36-40,45-47,49H,7-15,17-22H2,1-6H3/t23?,24-,25-,27?,28-,29+,30?,31?,32-,33-,34-,36?,37-,38-,39+,40+,41-,42-,43-/m0/s1	PDB UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	138	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Yeda Research and Development Co. Ltd. US Patent					Assay Description To screen for isoform selectivity of the digoxin derivatives we compared inhibition of Na,K-ATPase activity of purified detergent-soluble human isofo...				US Patent US10668094 (2020)
					More data for this Ligand-Target Pair